ArticleJournal of clinical microbiology2014
Phylogeny of the clinically relevant species of the emerging fungus Trichoderma and their antifungal susceptibilities.
Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry.The Journal of antimicrobial chemotherapy · 2022Pooled it
- Exploring the Skin Mycobiome: A Comparison of Skin Swabs and Tissue Specimens.Aesthetic plastic surgery · 2026Article
- Predicting bloodstream infection by plasma cell-free metagenomic sequencing: a prospective cohort study.The Lancet. Microbe · 2026Observational
- Phenogenomics reveals the ecology and evolution of Trichoderma fungi for sustainable agriculture.Nature microbiology · 2026Article
- Discovery of Trichoderma frianum sp. nov. from India: a new member of the Trichoderma harzianum species complex (Harzianum clade).International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Periprosthetic Joint Infection Caused by Trichoderma: Is It Plausible?Diagnostics (Basel, Switzerland) · 2025Article
- Eleven new species ofMycology · 2025Article
- Article
- Diversity ofFrontiers in microbiology · 2024Article
- Non-Journal of fungi (Basel, Switzerland) · 2023Review
- Review
- Two newMycoKeys · 2023Article
- Echinocandins - structure, mechanism of action and use in antifungal therapy.Journal of enzyme inhibition and medicinal chemistry · 2022Review
- Article
- Transcontinental Dispersal of Nonendemic Fungal Pathogens through Wooden Handicraft Imports.mBio · 2022Article
- Review
- Article
- Article
- New Species ofJournal of fungi (Basel, Switzerland) · 2021Article
- Decolorization kinetics and mass transfer mechanisms of Remazol Brilliant Blue R dye mediated by different fungi.Biotechnology reports (Amsterdam, Netherlands) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A set of 73 isolates of the emerging fungus Trichoderma isolated from human and animal clinical specimens were characterized morphologically and molecularly using a multilocus sequence analysis that included the internal transcribed spacer (ITS) regions of the nuclear ribosomal DNA and fragments of the translation elongation factor 1 alpha (Tef1), endochitinase CHI18-5 (Chi18-5), and actin 1 (Act1) genes. The most frequent species was Trichoderma longibrachiatum (26%), followed by Trichoderma citrinoviride (18%), the Hypocrea lixii/Trichoderma harzianum species complex (15%), the newly described species Trichoderma bissettii (12%), and Trichoderma orientale (11%). The most common anatomical sites of isolation in human clinical specimens were the respiratory tract (40%), followed by deep tissue (30%) and superficial tissues (26%), while all the animal-associated isolates were obtained from superficial tissue samples. Susceptibilities of the isolates to eight antifungal drugs in vitro showed mostly high MICs, except for voriconazole and the echinocandins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.